Miroslav Stýblo Selected Research

Glucose (Dextrose)

12/2023	Molecular and Metabolic Analysis of Arsenic-Exposed Humanized AS3MT Mice.
11/2023	Sex-specific transgenerational effects of preconception exposure to arsenite: metabolic phenotypes of C57BL/6 offspring.
12/2022	An interaction of inorganic arsenic exposure with body weight and composition on type 2 diabetes indicators in Diversity Outbred mice.
12/2017	Exposures to arsenite and methylarsonite produce insulin resistance and impair insulin-dependent glycogen metabolism in hepatocytes.
7/2017	Knockout of arsenic (+3 oxidation state) methyltransferase is associated with adverse metabolic phenotype in mice: the role of sex and arsenic exposure.
1/2017	Genetic and epigenetic mechanisms underlying arsenic-associated diabetes mellitus: a perspective of the current evidence.
8/2011	Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico.
8/2007	Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miroslav Stýblo Research Topics

Disease

10	Insulin Resistance 12/2023 - 08/2011
8	Neoplasms (Cancer) 01/2022 - 01/2003
5	Type 2 Diabetes Mellitus (MODY) 12/2023 - 08/2007
5	Diabetes Mellitus 01/2017 - 05/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2016
2	Body Weight (Weight, Body) 12/2022 - 11/2012
2	Acute Promyelocytic Leukemia 01/2022 - 01/2017
2	Hyperglycemia 01/2018 - 01/2017
2	Disease Susceptibility (Diathesis) 01/2017 - 10/2012
2	Glucose Intolerance 08/2011 - 08/2007
1	Anemia 02/2023
1	Birth Weight (Birth Weights) 01/2022
1	Insulinoma 11/2019
1	Hyperhomocysteinemia 01/2018
1	Obesity 07/2017
1	Carcinogenesis 06/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2015
1	Fetal Weight 11/2012
1	Hypertension (High Blood Pressure) 12/2011
1	Arsenic Poisoning 02/2011
1	Heart Neoplasms 02/2011
1	Poisoning 02/2011
1	Hepatocellular Carcinoma (Hepatoma) 07/2006

Drug/Important Bio-Agent (IBA)

20	ArsenicIBA 12/2023 - 01/2003
8	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 08/2007
7	Insulin (Novolin)FDA Link 12/2023 - 08/2011
6	Drinking WaterIBA 02/2023 - 08/2007
5	Blood Glucose (Blood Sugar)IBA 12/2023 - 08/2011
5	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 11/2012
3	MicroRNAs (MicroRNA)IBA 11/2019 - 04/2014
3	arseniteIBA 12/2017 - 12/2009
2	Arsenic Trioxide (Trisenox)FDA Link 01/2022 - 01/2017
2	methylarsoniteIBA 12/2017 - 02/2013
1	Hemoglobins (Hemoglobin)IBA 02/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	HomocysteineIBA 01/2022
1	CarbonIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2019
1	calcium-dependent protein kinaseIBA 11/2019
1	GlycogenIBA 12/2017
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	dimethylarsinous acidIBA 02/2013
1	S-AdenosylhomocysteineIBA 11/2012
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2011
1	Matrix Metalloproteinases (MMPs)IBA 12/2009
1	AgarIBA 12/2009
1	Selenious Acid (Selenite)IBA 12/2009
1	Small Interfering RNA (siRNA)IBA 07/2006
1	MetalloidsIBA 09/2005
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2003
1	DNA (Deoxyribonucleic Acid)IBA 01/2003